DOCUMENTATION AND COMMUNICATION. 4.1. You will pass on immediately to Us or the Client as applicable, without amendment (unless otherwise agreed by Us), any documentation which is either supplied by Us for the benefit of or completion by the Client, or provided by the Client in relation to the Application. You will advise Us of all material facts known by or divulged to You in relation to business undertaken or to be undertaken with Us.
DOCUMENTATION AND COMMUNICATION a. The Client hereby acknowledges that it has completed and submitted the account opening documentation requested by Xxxxx and further agrees to provide any additional information and supporting documentation as Cidel may request from time to time.
DOCUMENTATION AND COMMUNICATION. Pharmacists will document interventions in the patient’s electronic medical record after the patient encounter. Pharmacists will electronically route a note to the provider as deemed appropriate
DOCUMENTATION AND COMMUNICATION. 4.1 The Offeror agrees:
DOCUMENTATION AND COMMUNICATION. Services provided by LHCSA personnel -------------------------------- will be appropriately documented on forms specified and provided by LHCSA or by Mid Atlantic, depending on LHCSA's preference. All forms which are supplied by Mid Atlantic at LHCSA's option must comply with all applicable State and Federal regulations and conform to LHCSA's plans of treatment and care as established by LHCSA. Mid Atlantic will furnish copies of such documentation to the LHCSA within ten (10) business days of providing the services under this agreement. Telephone consultation with the LHCSA as needed to report any changes in the Patient's condition or circumstances, and to keep LHCSA's personnel appropriately informed of the patient's progress and/or problems which may arise.
DOCUMENTATION AND COMMUNICATION. AMIDEAST will keep a program image in order to brand the project according to USAID marking and branding guidelines. All AMIDEAST’s marketing products, such as pop-ups, roll-ups, posters, folders, binders and on-line materials will utilize the image. LTD’s public relations will focus its outreach to its main constituents, including teachers, principals district and ministry staff, USAID, teacher educators, international and local NGOs that work in the field of Education, and members of community organizations. Given the size and number of beneficiaries, an online newsletter will be published quarterly. The newsletter will consist of a series of brief articles about recent LTD achievements, activities, and events. It will include interviews with program participants and stakeholders, as well as articles written by other MoEHE public relations officers. The newsletter will be published in both Arabic and English. The AMIDEAST LTD website will be a venue for internal and external communication. It will provide information to visitors, partners, and participants about all aspects of the program. Content will include articles, pictures, activities, and notices of upcoming events. On a routine basis, LTD program managers and the Communications Officer will write press releases and news stories to be sent to local media outlets for publication. The Communications Officer will also use online social networking sites, such as Facebook and Twitter to post program-related content. The use of these on-line formats will be a means to reach all beneficiaries within the MoE, including participating schools and others involved or interested in the LTD program. Furthermore, the LTD Communications Officer will maintain a close working relationship with public relation officers of the school districts to ensure that all parties are involved in reaching out to the largest audience possible. During this Fiscal year the LTD communication component will work on the following activities:
DOCUMENTATION AND COMMUNICATION. 1. The Collaborating Physician shall be responsible for documenting the communication in the patient medical record maintained by the Collaborating Physician. The Collaborating Physician shall, within 24 hours, communicate to the Collaborating Pharmacist any changes initiated to a patient's drug therapy that is subject to an Agreement; a written, telephonic, or electronic prescription which contains specific dosage information may satisfy this requirement. The collaborating pharmacist shall, within 24 hours, communicate to the collaborating physician and any physician(s) designated by the patient any changes to a patient’s drug therapy and/or individual patient care services as set out in the Agreement. The Agreement shall describe the methods for Chapter 540-X-26 Medical Examiners documenting the patient medical record by the Collaborating Pharmacist and the Collaborating Physician, for documentation of services performed pursuant to the Agreement, and for communication and feedback between the Collaborating Pharmacist and the Collaborating Physician. All such records shall be maintained by the Collaborating Physician for a period of not less than six (6) years from the date of the last patient contact, or if the patient is a minor, the record shall be maintained for a period of not less than eight (8) years from the date of the last patient contact. All such records shall be maintained by the Collaborating Pharmacist within the employing pharmacy for a period of not less than two (2) years from the date of the last patient contact.
DOCUMENTATION AND COMMUNICATION. The Collaborating Physician shall be responsible for documenting the communication in the patient medical record maintained by the Collaborating Physician. The Collaborating Physician shall, within 24 hours, communicate to the Collaborating Pharmacist any changes initiated to a patient's drug therapy that is subject to an Agreement; a written, telephonic, or electronic prescription which contains specific dosage information may satisfy this requirement. The collaborating pharmacist shall, within 24 hours, communicate to the collaborating physician any changes to a patient’s drug therapy and/or individual patient care services as set out in the Agreement. The Agreement shall describe the methods for documenting the patient medical record by the Collaborating Pharmacist and the Collaborating Physician, for documentation of services performed pursuant to the Agreement, and for communication and feedback between the Collaborating Pharmacist and the Collaborating Physician. All such records shall be maintained by the Collaborating Physician for a period of not less than six (6) years from the date of the last patient contact, or if the patient is a minor, the record shall be maintained for a period of not less than eight (8) years from the date of the last patient contact. All such records shall be maintained by the Collaborating Pharmacist within the employing pharmacy for a period of not less than two (2) years from the date of the last patient contact.
DOCUMENTATION AND COMMUNICATION. Injector will document the procedure, results, client’s response, subsequent teachings and plan of care in the medical record as per CNO standard. All client’s assessment will be discussed and consulted with the medical director, medical director will authorize for require intervention. Injector will communicate with the medical director before any procedure. References/Guidelines/Rules: CNO practice standards. xxxx://xxx.xxx.xxx/en/learn-about-standards-guidelines/standards-and-guidelines/ CNO ethics. xxxx://xxx.xxx.xxx/globalassets/docs/prac/41034_ethics.pdf CNO Professional Standards xxxx://xxx.xxx.xxx/globalassets/docs/prac/41006_profstds.pdf Canadian Society of Aesthetic Specialty Nurses – 2015 xxxxx://xxxxx.xxx/wp-content/uploads/2018/07/2015-Practice-Guideline-and-Standards.pdf
DOCUMENTATION AND COMMUNICATION. 1. The Collaborating Physician shall be responsible for documenting the communication in the patient medical record maintained by the Collaborating Physician. The Collaborating Physician shall, within 24 hours, communicate to the Collaborating Pharmacist any changes initiated to a patient's drug therapy that is subject to an Agreement; a written, telephonic, or electronic prescription which contains specific dosage information may satisfy this requirement. The collaborating pharmacist shall, within 24 hours, communicate to the collaborating physician and any physician(s) designated by the patient any changes to a patient’s drug therapy and/or individual patient care services as set out in the Agreement. The Agreement shall describe the methods for documenting the patient medical record by the Collaborating Pharmacist and the Collaborating Physician, for documentation of services performed pursuant to the Agreement, and for communication and feedback between the Collaborating Pharmacist and the Collaborating Physician. All such records shall be maintained by the Collaborating Physician for a period of not less than six (6) years from the date of the last patient contact, or if the patient is a minor, the record shall be maintained for a period of not less than eight (8) years from the date of the last patient contact. All such records shall be maintained by the Collaborating Pharmacist within the employing pharmacy for a period of not less than two (2) years from the date of the last patient contact.
